Nicholas Investment Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Nicholas Investment Partners’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,202	Closed	-$3.67M	–	333
2015 Q2	$3.67M	Sell	15,202 -1,994	-12%	-$531K	0.24%	171
2015 Q1	$4.85M	Buy	17,196 +4,209	+32%	+$911K	0.3%	134
2014 Q4	$2.03M	Buy	12,987 +8,445	+186%	+$1.56M	0.13%	246
2014 Q3	$1.07M	Sell	4,542 -3,384	-43%	-$863K	0.07%	279
2014 Q2	$1.88M	Buy	+7,926	New	+$2.09M	0.11%	244

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Nicholas Investment Partners's ICPT Position: Q3 2015 in Review

Nicholas Investment Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2015, closing a stake of 15,202 shares — an estimated $3.67M sold.

Nicholas Investment Partners first reported a position in ICPT in Q2 2014 and held it in 5 quarters. The position peaked at $4.85M in Q1 2015. 173 funds tracked by Wall St. Rank hold ICPT as of Q3 2015.

Nicholas Investment Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Nicholas Investment Partners sold 15,202 Intercept Pharmaceuticals, Inc. shares in Q3 2015, an estimated $3.67M.
Nicholas Investment Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
Nicholas Investment Partners's Intercept Pharmaceuticals, Inc. position peaked at $4.85M in Q1 2015.
173 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2015.

Based on Nicholas Investment Partners's 13F filing for Q3 2015, filed 17 Nov 2015.